$AVAX

Currently breaking through a tough resistance zone, but price action since the February sell-off remains bullish.

With the trend reclaimed and price still holding above the weekly EMA, I expect a breakout in the coming weeks targeting $36.

Risk level: if $20 is lost, I’d be cautious holding that would open the door for a deeper retest toward $14.